NCT03539315 (ARCHES) is a NA clinical trial of ARCHES in Violence, Domestic, sponsored by Ipas.

Who is sponsoring NCT03539315?

NCT03539315 is sponsored by Ipas.

What drugs are being tested in NCT03539315?

Interventions in NCT03539315: ARCHES.

What condition does NCT03539315 study?

NCT03539315 studies Violence, Domestic.

Is NCT03539315 still recruiting?

NCT03539315 is currently completed. Last updated 5 September 2021.

Last reviewed 2021-09-05 · How we verify

NCT03539315: ARCHES

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adaptation and Testing of the Addressing Reproductive Coercion in HEalth Settings (ARCHES) Intervention in Bangladesh

Completed NA Last updated 5 September 2021

What this trial tests

NA trial testing ARCHES in Violence, Domestic in 2,729 participants. Completed in 15 January 2021.

Timeline

28 January 2019

Primary endpoint
15 January 2021

15 January 2021

Quick facts

Lead sponsor	Ipas
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	2,729
Start date	28 January 2019
Primary completion	15 January 2021
Estimated completion	15 January 2021
Sites	6 locations across Bangladesh

Drugs / interventions tested

ARCHES

Conditions studied

Violence, Domestic — all drugs for Violence, Domestic →

Sponsor

Ipas — full company profile →

Who can join

Adults 18 to 49, female only, with Violence, Domestic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary purpose of this research is to conduct a brief project to adapt and evaluate an evidence-based intervention model to address reproductive coercion and unintended pregnancy (ARCHES - Addressing Reproductive Coercion within Healthcare Settings) to the Bangladesh cultural context and for use with abortion clients (i.e., develop ARCHES Bangladesh) so as to provide initial assessment of acceptability, feasibility and effectiveness in this high-need LMIC context. Globally, addressing violence and coercion from male partners is considered key to reducing unintended pregnancy among adult and adolescent women. This has led to multiple efforts to integrate IPV screening and counseling in health settings, particularly in the context of family planning, across a range of middle and low-income countries. However, to date, no existing model addressing reproductive coercion has demonstrated reduction in risk for unintended pregnancy, either for Bangladesh or any other country.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Effectiveness of the Addressing Reproductive Coercion in Health Settings (ARCHES) intervention among abortion clients in Bangladesh: a cluster-randomized controlled trial.
Pearson E, Paul D, Menzel J, Shakhider MAH, et al · · 2024 · cited 4× · PMID 39040882 · DOI 10.1016/j.eclinm.2024.102699
The association between intimate partner violence and self-managed abortion: a cross-sectional study among women in urban Bangladesh.
Crouthamel B, Dixit A, Pearson E, Menzel J, et al · · 2022 · cited 1× · PMID 36001008 · DOI 10.1080/26410397.2022.2107078

Verify or expand the search:

Other recruiting trials for Violence, Domestic

Currently open trials in the same condition.

NCT06650267 — Substance Misuse and Family Violence Treatment Fathers · Phase 2 · recruiting
NCT05768217 — Community Resiliency Collective Efficacy Intervention · NA · recruiting
NCT04235335 — Healing Circles: An Intervention for Canadian Indigenous Mothers & Children Affected by IPV · NA · recruiting

Other Ipas trials

Trials by the same sponsor.

NCT04181541 — Midlevel Versus Physician-provided Medical Abortion in the Second Trimester · NA · completed
NCT04290832 — Developing and Testing Interventions to Address Conscientious Objection to Abortion Care in Mexico and South Africa · NA · terminated
NCT04242212 — Study of Clinic-based vs. Self-use of a Misoprostol-only Regimen for Induced Abortion · unknown
NCT03727308 — Study of Clinic-based Versus Self-use of Medical Abortion Pills · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03539315 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ipas
Last refreshed: 5 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03539315.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing